StonvexLoading…
StonvexStonvexStonvexCore line items from AMPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $719.89M | $731.97M | $644.39M | $498.99M |
Operating Income | $140.40M | $205.42M | $196.99M | $107.50M |
Net Income | $98.09M | $159.52M | $137.54M | $91.39M |
EPS (Diluted) | $2.03 | $3.06 | $2.60 | $1.74 |
Total Assets | $1.63B | $1.58B | $1.51B | $741.99M |
Total Liabilities | $840.49M | $845.17M | $873.49M | $213.33M |
Cash & Equivalents | $170.18M | $151.61M | $144.30M | $156.10M |
Free Cash Flow OCF − CapEx | $121.23M | $172.34M | $145.34M | $65.15M |
Shares Outstanding | 45.65M | 47.62M | 48.07M | 48.11M |